It is a powerful prognostic indicator for advanced breast cancer, as well as an independent predictor of breast cancer recurrence.[12,13] The tests for serum CEA, CA125, and CA15-3 are routinely used for patients with breast cancer[14]; however, their low sensitivities limit their clinical value. This evidence concerns the gene CEACAM5 and breast cancer.